United States (US) CRISPR and CAS Genes Market (2025-2031) | Segmentation, Industry, Value, Trends, Size & Revenue, Competitive Landscape, Companies, Analysis, Share, Growth, Forecast, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) CRISPR and CAS Genes Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) CRISPR and CAS Genes Market - Industry Life Cycle

3.4 United States (US) CRISPR and CAS Genes Market - Porter's Five Forces

3.5 United States (US) CRISPR and CAS Genes Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) CRISPR and CAS Genes Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing research and development activities in the field of genetic engineering and gene editing

4.2.2 Growing demand for personalized medicine and gene therapy

4.2.3 Rising investments in biotechnology and pharmaceutical industries

4.3 Market Restraints

4.3.1 Regulatory uncertainties and ethical concerns surrounding gene editing technologies

4.3.2 High costs associated with CRISPR-Cas gene editing techniques

4.3.3 Limited awareness and understanding of CRISPR-Cas technology among healthcare professionals and the general public

6.1 United States (US) CRISPR and CAS Genes Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Vector-based Cas, 2021- 2031F

6.1.4 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By DNA-free Cas, 2021- 2031F

6.2 United States (US) CRISPR and CAS Genes Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Genome Engineering, 2021- 2031F

6.2.3 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Disease Models, 2021- 2031F

6.2.4 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Functional Genomics, 2021- 2031F

6.2.5 United States (US) CRISPR and CAS Genes Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) CRISPR and CAS Genes Market Export to Major Countries

7.2 United States (US) CRISPR and CAS Genes Market Imports from Major Countries

8.1 Number of clinical trials utilizing CRISPR-Cas technology in the US

8.2 Adoption rate of CRISPR-Cas gene editing tools by biotech and pharmaceutical companies

8.3 Number of patents filed related to CRISPR-Cas gene editing technology in the US

8.4 Funding and investments in CRISPR-Cas research and development in the US

8.5 Rate of successful gene editing procedures using CRISPR-Cas technology in the US

9.1 United States (US) CRISPR and CAS Genes Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) CRISPR and CAS Genes Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) CRISPR and CAS Genes Market Revenue Share, By Companies, 2024

10.2 United States (US) CRISPR and CAS Genes Market Competitive Benchmarking, By Operating and Technical Parameters